124 related articles for article (PubMed ID: 16959320)
1. Synthesis, interaction with double-helical DNA and biological activity of the water soluble complex cis-dichloro-1,2-propylenediamine-N,N,N',N'-tetraacetato ruthenium (III) (RAP).
Vilaplana RA; Delmani F; Manteca C; Torreblanca J; Moreno J; García-Herdugo G; González-Vílchez F
J Inorg Biochem; 2006 Nov; 100(11):1834-41. PubMed ID: 16959320
[TBL] [Abstract][Full Text] [Related]
2. Biological activity and redistribution of nucleolar proteins of two different cell lines treated with cis-dichloro-1,2-propylenediamine-N,N,N',N'-tetraacetato ruthenium (III) (RAP).
Delmani FA; Torreblanca J; Moreno J; García-Herdugo G; Vilaplana R; González-Víltchez F
Indian J Exp Biol; 2014 Jun; 52(6):579-88. PubMed ID: 24956888
[TBL] [Abstract][Full Text] [Related]
3. DNA as a possible target for antitumor ruthenium(III) complexes.
Gallori E; Vettori C; Alessio E; Vilchez FG; Vilaplana R; Orioli P; Casini A; Messori L
Arch Biochem Biophys; 2000 Apr; 376(1):156-62. PubMed ID: 10729201
[TBL] [Abstract][Full Text] [Related]
4. DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.
Novakova O; Chen H; Vrana O; Rodger A; Sadler PJ; Brabec V
Biochemistry; 2003 Oct; 42(39):11544-54. PubMed ID: 14516206
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes.
Tan C; Liu J; Chen L; Shi S; Ji L
J Inorg Biochem; 2008 Aug; 102(8):1644-53. PubMed ID: 18468690
[TBL] [Abstract][Full Text] [Related]
6. Intercalation into the DNA double helix and in vivo biological activity of water-soluble planar [Pt(diimine)(N,N-dihydroxyethyl-N'-benzoylthioureato)]+Cl- complexes: a study of their thermal stability, their CD spectra and their gel mobility.
Wu YS; Koch KR; Abratt VR; Klump HH
Arch Biochem Biophys; 2005 Aug; 440(1):28-37. PubMed ID: 16009327
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and in vitro evaluation of a potentially selective anticancer, mixed-metal [ruthenium(III)-platinum(II)] trinuclear complex.
Herman A; Tanski JM; Tibbetts MF; Anderson CM
Inorg Chem; 2008 Jan; 47(1):274-80. PubMed ID: 18062685
[TBL] [Abstract][Full Text] [Related]
8. Topoisomerase II antagonism and anticancer activity of coordinated derivatives of [RuCl(2)(C(6)H(6))(dmso)].
Vashisht Gopal YN; Konuru N; Kondapi AK
Arch Biochem Biophys; 2002 May; 401(1):53-62. PubMed ID: 12054487
[TBL] [Abstract][Full Text] [Related]
9. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
Ruiz J; Vicente C; de Haro C; Bautista D
Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164
[TBL] [Abstract][Full Text] [Related]
10. In vitro expression and redistribution of nucleolar proteins following the treatment with cis-dichloro-1,2-propylenediamine-N,N,N',N'-tetraacetato ruthenium (III) (RAP).
Delmani FA; Torreblanca J; Moreno J; García-Herdugo G; Vilaplana R; González-Víltchez F
Oncol Res; 2009; 17(9):425-35. PubMed ID: 19718949
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, interaction with DNA and cytotoxicity of the new potential antitumour drug cis-K[Ru(eddp)Cl(2)].
Grguric-Sipka SR; Vilaplana RA; Pérez JM; Fuertes MA; Alonso C; Alvarez Y; Sabo TJ; González-Vílchez F
J Inorg Biochem; 2003 Oct; 97(2):215-20. PubMed ID: 14512200
[TBL] [Abstract][Full Text] [Related]
12. Studies of interaction of dichloro[eta2-dimethyl-(2-methylidene-cyclohexylmethyl)-amino]platinum(II) with DNA: effects on secondary and tertiary structures of DNA - cytotoxic assays on human cancer cell lines Capan 1 and A431.
Gay M; Montaña AM; Moreno V; Prieto MJ; Llorens R; Ferrer L
J Inorg Biochem; 2005 Dec; 99(12):2387-94. PubMed ID: 16256201
[TBL] [Abstract][Full Text] [Related]
13. Study of the biological effects and DNA damage exerted by a new dipalladium-Hmtpo complex on human cancer cells.
Akdi K; Vilaplana RA; Kamah S; Navarro JA; Salas JM; González-Vílchez F
J Inorg Biochem; 2002 May; 90(1-2):51-60. PubMed ID: 12009255
[TBL] [Abstract][Full Text] [Related]
14. The ruthenium complex cis-(dichloro)tetraammineruthenium(III) chloride presents selective cytotoxicity against murine B cell lymphoma (A-20), murine ascitic sarcoma 180 (S-180), human breast adenocarcinoma (SK-BR-3), and human T cell leukemia (Jurkat) tumor cell lines.
Silveira-Lacerda Ede P; Vilanova-Costa CA; Hamaguchi A; Pavanin LA; Goulart LR; Homsi-Brandenburgo MI; Dos Santos WB; Soares AM; Nomizo A
Biol Trace Elem Res; 2010 Jun; 135(1-3):98-111. PubMed ID: 19727575
[TBL] [Abstract][Full Text] [Related]
15. Analysis in vivo of antitumor activity, cytotoxicity and Interaction between plasmid DNA and the cis-dichloro-tetra-amine-ruthenium(III) chloride.
Menezes CS; de Paula Costa LC; de Melo Rodrigues Avila V; Ferreira MJ; Vieira CU; Pavanin LA; Homsi-Brandeburgo MI; Hamaguchi A; de Paula Silveira-Lacerda E
Chem Biol Interact; 2007 Apr; 167(2):116-24. PubMed ID: 17368594
[TBL] [Abstract][Full Text] [Related]
16. DNA interaction and antiproliferative behavior of the water soluble platinum supramolecular squares [(en)Pt(N-N)]4(NO3)8 (en=ethylenediamine, N-N=4,4'-bipyridine or 1,4-bis(4-pyridyl)tetrafluorobenzene).
Mounir M; Lorenzo J; Ferrer M; Prieto MJ; Rossell O; Avilès FX; Moreno V
J Inorg Biochem; 2007 Apr; 101(4):660-6. PubMed ID: 17292966
[TBL] [Abstract][Full Text] [Related]
17. DNA structural distortions induced by ruthenium-arene anticancer compounds.
Gossens C; Tavernelli I; Rothlisberger U
J Am Chem Soc; 2008 Aug; 130(33):10921-8. PubMed ID: 18651736
[TBL] [Abstract][Full Text] [Related]
18. Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.
van Rijt SH; Hebden AJ; Amaresekera T; Deeth RJ; Clarkson GJ; Parsons S; McGowan PC; Sadler PJ
J Med Chem; 2009 Dec; 52(23):7753-64. PubMed ID: 19791745
[TBL] [Abstract][Full Text] [Related]
19. The ruthenium complex cis-(Dichloro)Tetraammineruthenium(III) chloride presents immune stimulatory activity on human peripheral blood mononuclear cells.
Silveira-Lacerda Ede P; Vilanova-Costa CA; Pereira Fde C; Hamaguchi A; Pavanin LA; Goulart LR; Homsi-Brandenburgo MI; Soares AM; dos Santos WB; Nomizo A
Biol Trace Elem Res; 2010 Mar; 133(3):270-83. PubMed ID: 19590831
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cancer cell growth by ruthenium(II) cyclopentadienyl derivative complexes with heteroaromatic ligands.
Helena Garcia M; Morais TS; Florindo P; Piedade MF; Moreno V; Ciudad C; Noe V
J Inorg Biochem; 2009 Mar; 103(3):354-61. PubMed ID: 19128838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
